Construction and Validation of a New Model for the Prediction of Rupture in Patients with Intracranial Aneurysms

World Neurosurg. 2021 May:149:e437-e446. doi: 10.1016/j.wneu.2021.02.006. Epub 2021 Feb 7.

Abstract

Background: Despite progress in the detection of biological molecules that contribute to intracranial aneurysm (IA) development, many pathophysiological mechanisms remain unclear, particularly with regard to predicting IA rupture. In this study, we aimed to identify hub genes and construct a new model to predict IA rupture.

Methods: Four datasets (62 ruptured IAs, 16 unruptured IAs, and 31 normal controls) were downloaded from the Gene Expression Omnibus. Differentially expressed genes (DEGs) were identified between the IAs and normal controls. All overlapping genes were analyzed using weighted gene co-expression network analysis. Functional enrichment analyses were performed using key modules. We then intersected the key module genes with DEGs. Protein-protein interaction networks were assessed to identify key hub genes. Least absolute shrinkage and selection operator logistic regression analysis was performed to construct a prediction model. A receiver operating characteristic curve was constructed to evaluate the reliability of the scoring system.

Results: After intersection and normalization, 433 DEGs were identified and 15,388 genes were selected for weighted gene co-expression network analysis. The black module with 1145 genes exhibited the highest correlation with IA rupture. Many potential mechanisms are involved, such as the inflammatory response, innate immune response, extracellular exosome, and extracellular space. Thirty hub genes were selected from the protein-protein interaction, and 4 independent risk genes, TNFAIP6, NCF2, OSM, and IRAK3, were identified in the least absolute shrinkage and selection operator logistic regression model.

Conclusions: Our prediction model not only serves as a useful tool for assessing the risk of IA rupture, but the key genes identified herein could also serve as biomarkers and therapeutic targets.

Keywords: Biomarkers; Hub genes; Intracranial aneurysm; Rupture; WGCNA.

Publication types

  • Validation Study

MeSH terms

  • Aneurysm, Ruptured / genetics*
  • Aneurysm, Ruptured / immunology
  • Aneurysm, Ruptured / metabolism
  • Cell Adhesion Molecules / genetics
  • Databases, Genetic
  • Exosomes / genetics
  • Extracellular Space / genetics
  • Gene Regulatory Networks
  • Humans
  • Immunity, Innate / genetics
  • Inflammation / genetics
  • Interleukin-1 Receptor-Associated Kinases / genetics
  • Intracranial Aneurysm / genetics*
  • Intracranial Aneurysm / immunology
  • Intracranial Aneurysm / metabolism
  • Logistic Models
  • NADPH Oxidases / genetics
  • Oncostatin M / genetics
  • Protein Interaction Maps
  • ROC Curve
  • Reproducibility of Results
  • Risk Assessment
  • Transcriptome

Substances

  • Cell Adhesion Molecules
  • OSM protein, human
  • TNFAIP6 protein, human
  • Oncostatin M
  • NADPH Oxidases
  • NCF2 protein, human
  • IRAK3 protein, human
  • Interleukin-1 Receptor-Associated Kinases